Please assess the completion status of the following clinical trial:

Trial Title: A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Individuals age 18 and older with schizophrenia or schizoaffective disorder as confirmed by the Mini International Psychiatric Inventory (MINI). The investigators will use a DSM-5 concordant version of the MINI if it is available at the time that the first study participant is enrolled.~* Individuals who are currently or have been recently homeless (within the past 12 months) as per revised federal definition of homelessness (Homeless Emergency Assistance and Rapid Transition to Housing. In: Development DoHaU, ed2011.)~* Known to have medication treatment adherence problems as identified by the Treatment Routines Questionnaire (TRQ, 20% or more missed medications in past week or past month)~* Ability to be rated on psychiatric rating scales.~* Willingness to take long-acting injectable medication~* Currently in treatment at a Community Mental Health Clinic (CMHC) or other treatment setting able to provide mental health care during and after study participation~* Able to provide written, informed consent to study participation.~Exclusion Criteria:~* Individuals on long-acting injectable antipsychotic medication immediately prior to study enrollment.~* Prior or current treatment with clozapine~* Medical condition or illness, which in the opinion of the research psychiatrist, would interfere with the patient's ability to participate in the trial~* Physical dependence on substances (alcohol or illicit drugs) likely to lead to withdrawal reaction during the course of the study in the clinical opinion of the treated research psychiatrist~* Immediate risk of harm to self or others~* Female who is currently pregnant or breastfeeding~* Individual who is already in permanent and supported housing that includes comprehensive mental health services (i.e. Housing First)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CAE-L (Type: EXPERIMENTAL): Eight sessions of the manualized intervention, Customized Adherence Enhancement (CAE), will be delivered along with a long-acting injectable antipsychotic (either haloperidol decanoate or paliperidone palmitate dosed per package insert) over the course of six weeks. Study staff will also communicate with the participant's mental health provider to help ensure treatment continuation after study end.

Based on this trial design, predict the completion outcome and termination type (if applicable).